Nanocarriers and macrophage interaction: from a potential hurdle to an alternative therapeutic strategy

• Naths Grazia Sukubo,
• Paolo Bigini and
• Annalisa Morelli

Beilstein J. Nanotechnol. 2025, 16, 97–118, doi:10.3762/bjnano.16.10

Attempts to preserve and visualize protein corona on the surface of biological nanoparticles in blood serum using photomodification

• Julia E. Poletaeva,
• Anastasiya V. Tupitsyna,
• Alina E. Grigor’eva,
• Ilya S. Dovydenko and
• Elena I. Ryabchikova

Beilstein J. Nanotechnol. 2024, 15, 1654–1666, doi:10.3762/bjnano.15.130

• results showed that a protein corona is present on extracellular vesicles and lipoproteins isolated by UC. The isolation of bio-NPs through sucrose gradient or cushion did not preserve the protein corona. At the same time, we observed signs of a negative effect of the sucrose gradient on bio-NPs of intact

• obtained direct images of a “natural” protein corona on natural bio-NPs of blood serum for the first time Keywords: chylomicrons; extracellular vesicles; lipoproteins; photomodification; protein corona; Introduction The existence of a protein corona on all nanoparticles (NPs) entering biological fluids

• are increasingly interested in studying the protein corona on extracellular vesicles (EVs), mainly exosomes, which play an important role in the transmission of molecular signals in the body. The influence of the protein corona on EVs on their interaction with body cells, including cells of the immune

Biomimetic nanocarriers: integrating natural functions for advanced therapeutic applications

• Hugo Felix Perini,
• Beatriz Sodré Matos,
• Carlo José Freire de Oliveira and
• Marcos Vinicius da Silva

Beilstein J. Nanotechnol. 2024, 15, 1619–1626, doi:10.3762/bjnano.15.127

• these carriers are improved [19][21][22][23][24][25]. Various cellular components such as extracellular vesicles, leukocyte and red blood cell membranes are beneficial for developing bioinspired devices. Specific targets, including peptides, aptamers, proteins, and viral capsids, may also be utilized in

Entry of nanoparticles into cells and tissues: status and challenges

• Kirsten Sandvig,
• Tore Geir Iversen and
• Tore Skotland

Beilstein J. Nanotechnol. 2024, 15, 1017–1029, doi:10.3762/bjnano.15.83

• excretion. Finally, we discuss requirements for bringing NPs into clinical use and aspects when it comes to usage of complex and slowly degraded or nondegradable NPs. Keywords: biodegradable; biodistribution; endocytosis; extracellular vesicles; nanomedicine; nanoparticles; Introduction Nanoparticles (NPs

• other types of vesicles, for instance from the plasma membrane, may play a role in the transfer of information between cells. For a list of various types of extracellular vesicles (EVs), see [5]. For therapeutic purposes, EVs may not only be loaded with drugs after the release from cells, but incubation

Cholesterol nanoarchaeosomes for alendronate targeted delivery as an anti-endothelial dysfunction agent

• Horacio Emanuel Jerez,
• Yamila Roxana Simioni,
• Kajal Ghosal,
• Maria Jose Morilla and
• Eder Lilia Romero

Beilstein J. Nanotechnol. 2024, 15, 517–534, doi:10.3762/bjnano.15.46

• types respond to LPS stimulation with more irritation; FCs are known to facilitate pathogenesis by producing eicosanoids, tissue-damaging enzymes, and extracellular vesicles [86]. The resultant responses diffused either downwards or upwards across the porous membrane, constituting what we called a

Elasticity, an often-overseen parameter in the development of nanoscale drug delivery systems

• Agnes-Valencia Weiss and
• Marc Schneider

Beilstein J. Nanotechnol. 2023, 14, 1149–1156, doi:10.3762/bjnano.14.95

• with a model hydrogel that there is a higher penetration for more deformable extracellular vesicles from mouse mesenchymal stromal cells [37]. A second study, from Yu et al., shows rigidity-dependent penetration of lipid NPs in the mucus layer of rat intestinal mucus. Liposomes were either hollow or

Green SPIONs as a novel highly selective treatment for leishmaniasis: an in vitro study against Leishmania amazonensis intracellular amastigotes

• Brunno R. F. Verçoza,
• Robson R. Bernardo,
• Luiz Augusto S. de Oliveira and
• Juliany C. F. Rodrigues

Beilstein J. Nanotechnol. 2023, 14, 893–903, doi:10.3762/bjnano.14.73

• ultrastructural changes were observed in intracellular amastigotes: (1) many lipid bodies (A–C, thin arrows), (2) increased secretion of extracellular vesicles (A–C, broad arrows), (3) intracellular vacuolization (A–C, arrows), (4) myelin-like figures (A, arrowhead), (5) mitochondrial swelling (C, star), and (6

The steep road to nonviral nanomedicines: Frequent challenges and culprits in designing nanoparticles for gene therapy

• Yao Yao,
• Yeongun Ko,
• Grant Grasman,
• Jeffery E. Raymond and
• Joerg Lahann

Beilstein J. Nanotechnol. 2023, 14, 351–361, doi:10.3762/bjnano.14.30

• measurement. For NTA, ASTM 2834 provides workflows for planning NP experiments. Through the study of nanoscale extracellular vesicles, Bachurski et al. [68] provide some additional insights comparing the performance of different NTA systems to cryo-TEM and single-particle interferometric reflectance imaging

Recent progress in cancer cell membrane-based nanoparticles for biomedical applications

• Qixiong Lin,
• Yueyou Peng,
• Yanyan Wen,
• Xiaoqiong Li,
• Donglian Du,
• Weibin Dai,
• Wei Tian and
• Yanfeng Meng

Beilstein J. Nanotechnol. 2023, 14, 262–279, doi:10.3762/bjnano.14.24

• membranes have been exploited for the development of novel membrane NP-based therapies, such as erythrocytes [10], platelets [11], cancer cells [14], stem cells [12], immune cells [13], central nervous system-derived cells [17], bacterial outer membrane vesicles [18], and extracellular vesicles [19]. Cancer

The role of convolutional neural networks in scanning probe microscopy: a review

• Ido Azuri,
• Irit Rosenhek-Goldian,
• Neta Regev-Rudzki,
• Georg Fantner and
• Sidney R. Cohen

Beilstein J. Nanotechnol. 2021, 12, 878–901, doi:10.3762/bjnano.12.66

Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications

• Sepand Tehrani Fateh,
• Lida Moradi,
• Elmira Kohan,
• Michael R. Hamblin and
• Amin Shiralizadeh Dezfuli

Beilstein J. Nanotechnol. 2021, 12, 808–862, doi:10.3762/bjnano.12.64

• on triggering exocytosis leading to the release of extracellular vesicles [187]. Microbubbles were first developed as contrast agents and then were used in cargo delivery. Nowadays, they play a role as theranostic agents [178][188]. Many studies have shown that the concurrent use of MBs and US

Bio-imaging with the helium-ion microscope: A review

• Matthias Schmidt,
• James M. Byrne and
• Ilari J. Maasilta

Beilstein J. Nanotechnol. 2021, 12, 1–23, doi:10.3762/bjnano.12.1

Integrated photonics multi-waveguide devices for optical trapping and Raman spectroscopy: design, fabrication and performance demonstration

• Gyllion B. Loozen,
• Arnica Karuna,
• Mohammad M. R. Fanood,
• Erik Schreuder and
• Jacob Caro

Beilstein J. Nanotechnol. 2020, 11, 829–842, doi:10.3762/bjnano.11.68

• scale) and the mass producibility. In [6], we presented a detailed simulation study of the trapping capabilities for extracellular vesicles (EVs) of the dual-waveguide trap we used in [5]. EVs are small cell-derived particles (diameter ranging from 30 to 1000 nm) and are important as potential

• powers of several milliwatts. Thus, we have quite some power left for making the transition to stable trapping of, for example, bacteria, human cells or extracellular vesicles. The 16-waveguide device is the better choice in this respect, since Table 1 indicates that it clearly has a higher trap